ArticleFrontiers in pharmacology2023

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.

Aparna Narendrula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.